| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0278678|metastatic renal cell carcinoma |
| Sentences | 2 |
| PubMedID- 23924450 | Evaluation of efficacy and safety of sunitinib regimen in 22 patients with metastatic renal cell carcinoma: at least 12-month follow-up. |
| PubMedID- 22013228 | This study assessed the response rates and toxicity profiles of sunitinib on a continuous once-daily dosing regimen in turkish patients with metastatic renal cell carcinoma. |
Page: 1